Keyphrases
5-HT2
60%
5-hydroxytryptamine
20%
Acute-on-chronic
20%
Antipsychotics
40%
Atypical Antipsychotics
40%
Beneficial Effects
20%
Beta-blockers
20%
Brief Psychiatric Rating Scale
40%
Chronic Treatment
40%
Clinical Status
20%
Combined Treatment
20%
D2 Antagonist
20%
D2 Receptor
20%
Double-blind Design
20%
Haloperidol
20%
Hamilton Depression Rating Scale (HAM-D)
20%
HT-2
20%
Mianserin
100%
Perphenazine
20%
Placebo
100%
Positive Symptoms
40%
Psychotic
40%
Receptor Blockade
20%
Scale for the Assessment of Negative Symptoms
20%
Schizophrenic Patients
20%
Serotonergic
20%
Symptom Scale
20%
Symptom Score
40%
Treatment-resistant Schizophrenia
100%
Typical Antipsychotics
100%
Typical Neuroleptics
20%
Neuroscience
5-HT2 Antagonists
20%
Atypical Antipsychotic
40%
D2 Antagonists
20%
Dopaminergic
20%
Haloperidol
20%
Hamilton Rating Scale for Depression
20%
Mianserin
100%
Negative Syndrome
20%
Perphenazine
20%
Placebo
100%
Positive Syndrome
40%
Receptor
20%
Serotonergic
20%
Treatment-Resistant Schizophrenia
80%
Typical Antipsychotic
100%
Pharmacology, Toxicology and Pharmaceutical Science
4 (para chlorophenyl) 1 [3 (para fluorobenzoyl)propyl] 4 piperidinol
20%
Atypical Antipsychotics
40%
Diseases
20%
Dopamine Receptor Stimulating Agent
20%
Mianserin
100%
Negative Syndrome
20%
Perphenazine
20%
Placebo
100%
Positive Syndrome
40%
Receptor
20%
Serotonin 2 Antagonist
20%
Treatment-Resistant Schizophrenia
80%
Typical Antipsychotic
100%